|
The scientific and medical communities, including the
Dr. Qanta Ahmed, MD, pulmonologist at NYU Langone, also pushed for more use of UV-C light air purifiers in an
The
How does UV-C light work on COVID-19? - Coronaviruses, including SARS-CoV-2 which causes COVID 19, are RNA viruses enveloped in a lipid bilayer. 4 UV-C light in the 254 nm wavelength inactivates lipid viruses by damaging their DNA and RNA genetic material.4,5,6,7,8 UV light’s germicidal effectiveness is influenced by UV intensity, which is affected by distance.4
How does RxAir UV-C Light Air Purification work? --The RxAir UV-C light air purifier is uniquely effective because its patented “kill chamber” forces the air to spiral in close proximity around the three 10-inch UV-C tubes for an extended period of time, ensuring the proper 254 nm wavelength dosage for maximum microbicidal activity. 4, 6 , 9, 10, 11
- RxAir 400 UV Light air purifier - inactivates or kills more than 99.9% of airborne viruses and bacteria, providing up to six air changes per hour (ACH) for an 800 to 1000 sq. ft. area. 9, 10, 11
- Rx3000 UV Light/HEPA air purifier - inactivates and captures 99.97% of viruses and pathogens on first pass with four to eight ACH for a 1500 sq. ft. surgical suite or infection control room or four ACH for a 3000 sq. ft. non-surgical room. 9, 10, 11
RxAir air purifiers are portable standalone units designed for use in a single room of a home, classroom, office, healthcare facility, restaurant or business. They can be valuable supplements to heating, ventilation and air conditioning (HVAC) systems by providing rooms with much higher ACH rates than the HVAC system while inactivating, rather than trapping, the pathogens.
Is UV light safe? --UV light is a known carcinogen that can harm the eyes and skin from just moments of direct exposure. RxAir protects consumers from exposure to the UV light by enclosing the bulbs within the unit. RxAir is completely safe for major reduction in ambient level of airborne coronaviruses in occupied spaces. This is a major contrast to UV-C robot- or ceiling- mounted unshielded UV-C lights that can only be used in vacant rooms.
UV-C Light and Indoor Air Quality -- Research shows that in addition to viruses and bacteria, allergenic pollens, mold, fungi and harmful pollutants contribute to poor indoor air quality (IAQ) that causes respiratory and heart disease, cancer, difficulty breathing, headaches, dizziness, and asthma.12 RxAir UV-C light air purifiers have been proven effective against harmful viral and bacterial pathogens (including multiple coronaviruses, H1N1, MRSA, pneumonia, strep, TB, measles, influenza, and the common cold), molds, and fungi in addition to neutralizing odors, VOCs (volatile organic compounds) and other indoor pollutants 5, 6, 7.
Supplementary vs Primary Disinfection -- The
For information on how to become an RxAir/Rx3000 distributor and/or bulk pricing, contact
Lee Howley, lhowley@vytex.com
Follow
Twitter: @VystarCompany
#RxAir , #Coronavirus, #Covid, #UVLight, #UVdisinfection
Sources:
1 Prather K., Marr L., Schooley R. et al., Airborne transmission of SARS-CoV-2, Science,
2
https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-sars-cov-2.html (Accessed
3
4
5 Kowalski, Walsh, Petraitis (2020, March) 2020 COVID-19 Coronavirus Ultraviolet Susceptibility, https://www.researchgate.net/publication/339887436_2020_COVID-19_Coronavirus_Ultraviolet_Susceptibility, Accessed
6 Coffey, Donavyn, Does UV light kill the new coronavirus?, (
7
8 Sabino, Ball, Baptista, et al, Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency, I,
9 Kowalski, (2013, June) Residential Application of the RxAir UV light Portable Air Purification Unit, https://www.rxair.com/lab_results/residential-application/
10 Kowalski, (2009,
11 Kowalski, (2012, Jan20) Supplemental Air Purification for Hospitals and Health Care Facilities, https://www.rxair.com/lab_results/health-care-facilities/
12
Financial Disclosure: Dr.
# # #
About
Based in
Contacts:
Media:
Investors: Lee Howley, lhowley@vytex.com 508-791-9114
Distributor Opportunities:
Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, product development and delivery, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements.
Attachments
- Vystar Corporation’s
- Vystar Corporation’s
Source:
2020 GlobeNewswire, Inc., source